Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Dravet Syndrome: Results Overall and for Patients Completing 1-3 Years of an Open-Label Extension (GWPCARE5)

被引：0

作者：

Nabbout, R. ^{[1
]}

Sanchez-Carpintero, R. ^{[2
]}

Halford, J. J. ^{[3
]}

Shiloh-Malawsky, Y. ^{[4
]}

Scheirer, I. E. ^{[5
,6
]}

Wong, M. ^{[7
]}

Checketts, D. ^{[8
]}

Dunayevich, E. ^{[9
]}

机构：

[1] Necker Enfants Malad Hosp, Paris, France

[2] Clin Univ Navarra, Madrid, Spain

[3] Med Univ South Carolina, Charleston, SC 29425 USA

[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA

[5] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia

[6] Royal Childrens Hosp, Melbourne, Vic, Australia

[7] Wake Forest Baptist Med Ctr, Winston Salem, NC USA

[8] GW Res Ltd, Cambridge, MA USA

[9] Greenwich Biosci Inc, Carlsbad, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR3033

引用

页码：435 / 435

页数：1